Suppressors for Human Epidermal Growth Factor Receptor 2/4 (HER2/4): A New Family of Anti-Toxoplasmic Agents in ARPE-19 Cells
Yeong Hoon Kim, Lokraj Bhatt, Hye-Jin Ahn, Zhaoshou Yang, Won-Kyu Lee, Ho-Woo Nam
Korean J Parasito. 2017;55(5):491-503. Published online 2017 Oct 31 DOI: https://doi.org/10.3347/kjp.2017.55.5.491
Citations to this article as recorded by 
The antimicrobial activity of innate host-directed therapies: A systematic review
Tirosh Shapira, Matthew Christofferson, Yossef Av-Gay
International Journal of Antimicrobial Agents.2024; 63(5): 107138. CrossRef
Novel therapeutic opportunities for Toxoplasma gondii, Trichomonas vaginalis, and Giardia intestinalis infections
Francesca Arrighi, Arianna Granese, Paola Chimenti, Paolo Guglielmi
Expert Opinion on Therapeutic Patents.2023; 33(3): 211. CrossRef
Latent Toxoplasmosis among Breast Cancer Patients in Jahrom, South of Iran
Marzeieh Haghbin, Salar Maani, Mohammad Aref Bagherzadeh, Ahmadreza Bazmjoo, Heshmatollah Shakeri, Ali Taghipour, Shahab Falahi, Azra Kenarkoohi, Milad Badri, Amir Abdoli, Mubashir Javed Mintoo
International Journal of Breast Cancer.2023; 2023: 1. CrossRef
Discovery of N-(3-bromo-1H-indol-5-yl)-quinazolin-4-amine as an effective molecular skeleton to develop reversible/irreversible pan-HER inhibitors
Qidong Tang, Ting Peng, Jie Hu, Tao Zhang, Pengqin Chen, Daoxing Chen, Yunjie Wang, Lingfeng Chen, Linjiang Tong, Yi Chen, Hua Xie, Guang Liang
European Journal of Medicinal Chemistry.2022; 233: 114249. CrossRef
Secretome Analysis of Host Cells Infected with Toxoplasma gondii after Treatment of Human Epidermal Growth Factor Receptor 2/4 Inhibitors
Hye-Jung Kim, Hye-Jin Ahn, Hyeweon Kang, Jaehui Park, Seul gi Oh, Saehae Choi, Won-Kyu Lee, Ho-Woo Nam
The Korean Journal of Parasitology.2020; 58(3): 249. CrossRef